These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 2950127)

  • 1. Atrial natriuretic peptide during mineralocorticoid escape in the human.
    Zimmerman RS; Edwards BS; Schwab TR; Heublein DM; Burnett JC
    J Clin Endocrinol Metab; 1987 Mar; 64(3):624-7. PubMed ID: 2950127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human atrial natriuretic polypeptide during escape from mineralocorticoid excess in man.
    Miyamori I; Ikeda M; Matsubara T; Okamoto S; Koshida H; Morise T; Takeda R
    Clin Sci (Lond); 1987 Oct; 73(4):431-6. PubMed ID: 2959429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in the plasma levels of atrial natriuretic peptides during mineralocorticoid escape in man.
    Cappuccio FP; Markandu ND; Buckley MG; Sagnella GA; Shore AC; MacGregor GA
    Clin Sci (Lond); 1987 May; 72(5):531-9. PubMed ID: 2953526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sodium excretion and atrial natriuretic peptide levels during mineralocorticoid administration. A mechanism for the escape from hyperaldosteronism.
    Kelly TM; Nelson DH
    Endocr Res; 1987; 13(4):363-83. PubMed ID: 2966064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma levels of atrial natriuretic peptide (ANP) during mineralocorticoid escape in normal man.
    Wambach G; Götz S; Suckau G; Kaufmann W
    Klin Wochenschr; 1986; 64 Suppl 6():53-7. PubMed ID: 2948064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Renal resistance to atrial natriuretic factor as a cause of the escape failure phenomenon in patients with non-ascitic liver cirrhosis].
    Tesar V; Spicák J; Horký K; Zabka J; Widimský J; Jedlicka J; Marecek Z
    Cas Lek Cesk; 1994 Feb; 133(4):111-5. PubMed ID: 8137382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atrial natriuretic peptide and plasma renin levels in assessment of mineralocorticoid replacement in Addison's disease.
    Cohen N; Gilbert R; Wirth A; Casley D; Jerums G
    J Clin Endocrinol Metab; 1996 Apr; 81(4):1411-5. PubMed ID: 8636343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of atrial natriuretic peptide in mineralocorticoid escape phenomenon in patients with primary aldosteronism.
    Nakamura T; Ichikawa S; Sakamaki T; Sato K; Kogure M; Tajima Y; Kato T; Murata K
    Proc Soc Exp Biol Med; 1987 Sep; 185(4):448-54. PubMed ID: 2956609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated levels of atrial natriuretic peptide during aldosterone escape.
    Granger JP; Burnett JC; Romero JC; Opgenorth TJ; Salazar J; Joyce M
    Am J Physiol; 1987 May; 252(5 Pt 2):R878-82. PubMed ID: 2953258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The effects of the acute administration of atrial natriuretic peptide on the mechanisms regulating diuresis and natriuresis in the essential hypertension patient].
    Iannettone CM; Strazzulla G; Fabbri G; Piazza E; Valenza T; De Feo ML; Franchi F
    Ann Ital Med Int; 1991; 6(3):273-83. PubMed ID: 1837999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal effects of atrial natriuretic peptide infusion in young and adult rats.
    Chevalier RL; Gomez RA; Carey RM; Peach MJ; Linden JM
    Pediatr Res; 1988 Sep; 24(3):333-7. PubMed ID: 2850523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced natriuretic effect of atrial natriuretic factor during mineralocorticoid escape in humans.
    Gaillard CA; Koomans HA; Rabelink TJ; Braam B; Boer P; Dorhout Mees EJ
    Hypertension; 1988 Oct; 12(4):450-6. PubMed ID: 2971618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corticosteroid-induced stimulation of atrial natriuretic peptide in man.
    Saxenhofer H; Angst M; Weidmann P; Shaw SG; Ferrier C
    Acta Endocrinol (Copenh); 1988 Jun; 118(2):179-86. PubMed ID: 2968749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Increase in absolute atmospheric pressure in hyperbaric chamber in cirrhosis with ascites: lack of natriuretic response and increase of atrial natriuretic peptide].
    Gambini G; Fioroni E; Guerra M; Moscatelli A; Valori C
    Minerva Med; 1994 Mar; 85(3):77-81. PubMed ID: 8196847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pressure-dependent distal tubular action of atrial natriuretic peptide in healthy humans.
    Eiskjaer H; Nielsen CB; Pedersen EB
    J Hypertens; 1996 Jan; 14(1):99-106. PubMed ID: 12013501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal response to atrial natriuretic peptide in nonedematous sodium-retaining dogs.
    Levy M; Cernacek P
    Clin Invest Med; 1992 Apr; 15(2):150-8. PubMed ID: 1534292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atrial natriuretic peptide, sodium retention, and proteinuria in nephrotic syndrome.
    Plum J; Mirzaian Y; Grabensee B
    Nephrol Dial Transplant; 1996 Jun; 11(6):1034-42. PubMed ID: 8671965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucocorticoid and mineralocorticoid stimulation of atrial natriuretic peptide release in man.
    Weidmann P; Matter DR; Matter EE; Gnädinger MP; Uehlinger DE; Shaw S; Hess C
    J Clin Endocrinol Metab; 1988 Jun; 66(6):1233-9. PubMed ID: 2967304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liraglutide promotes natriuresis but does not increase circulating levels of atrial natriuretic peptide in hypertensive subjects with type 2 diabetes.
    Lovshin JA; Barnie A; DeAlmeida A; Logan A; Zinman B; Drucker DJ
    Diabetes Care; 2015 Jan; 38(1):132-9. PubMed ID: 25414155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Restoration of renal responsiveness to atrial natriuretic peptide in experimental nephrotic syndrome by albumin infusion.
    Abassi Z; Weissman I; Karram T; Goltsman I; Hoffman A; Better OS; Winaver J
    Am J Nephrol; 2013; 38(4):292-9. PubMed ID: 24080549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.